US Patent Issued to Catalent Ontario on Feb. 10 for "Methods of preparing multiphase statin and omega-3 fatty acid soft capsule formulations" (Canadian Inventors)

ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,544,341, issued on Feb. 10, was assigned to Catalent Ontario Ltd. (Windsor, Canada).

"Methods of preparing multiphase statin and omega-3 fatty acid soft capsule formulations" was invented by Peter Draper (Amherstburg, Canada), James Draper (LaSalle, Canada) and Beth Okutan (Lakeshore, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods of preparing multi-phase soft gelatin dosage forms comprising at least one preformed solid dosage form comprising a statin compound and at least one liquid fill phase comprising Omega-3 fatty acids. The multi-phase soft gelatin dosage forms combine at least one solid dosage form and at least one liquid phase for...